ÈùÏÙÑײ¡¶¾,Mumps virusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ì©°²,Tai anÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÍÁ×å,the TusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éç»áÊÊÓ¦ÄÜÁ¦,Social adaptabilityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« RhoGTPases,Rho GTPasesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« WesternÔÓ½»,Western blottingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿·ËáĪÃ×ËÉ,mometasone furoateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« NO_2,nitrogen dioxideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂýÐÔÔÙÕÏ,chronic aplastic anemiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾Þϸ°û²¡¶¾¸ÎÑ×,Cytomegalovirus hepatitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 9ºÅȾɫÌå,Chromosome 9Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« Öéµ°°×Éú³ÉÕÏ°­ÐÔ,dysfunction of globin productionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²¹Ìå3b,complement 3bÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Àɸñ¶ûººË¹Ï¸°û,Langerhans cellsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ºËÏ˲ã,Nuclear laminaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Cox·çÏÕÄ£ÐÍ,Cox risk modelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿ËÀײ®¸Ë¾ú,Klebsiella pneumoniaeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Å£Ä̵°°×,milk proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿ËÀ­Î¬Ëá¼Ø,Clavulanate potassiumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÀʸñººË¹Ï¸°û×é֯ϸ°ûÔöÉúÖ¢,Langerhans cell histiocytosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±ÇÑÊ·ÖÃÚÎï,Nasopharyngeal secretionsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ÉÈÅËئÁ-1b,interferon ¦Á-1bÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·Î¶¯Âö°ê·´Á÷,Pulmonary regurgitationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ó׶ùÔ°,KindergartenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Chediak-Higashi×ÛºÏÕ÷,Chediak-Higashi SyndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« С³¦Áܰ͹ÜÀ©ÕÅÖ¢,Intestinal lymphangiectasiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« GATA4»ùÒò,GATA4 geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²»µäÐÍ´¨Æ鲡,Atypical Kawasaki DiseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐÄÔ༡¸Æµ°°×I,cardiac troponin IÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶àÖػعé,multiple regressionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²Î¿¼Æ½Ãæ,reference planeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÃŶ¬°±Ëá,aspartic acidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·ÎÑ׺ϼÁ,Pneumonia mixtureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ó¤Ó׶ù´­Ï¢,Infant wheezingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÆøÏàÉ«Æ×-ÖÊÆ×ÁªÓ÷ÖÎö,GC-MSÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« bro»ùÒò,bro geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²¹³äºÍÌæ´úҽѧ,complementary and alternative medicineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ô­·¢ÐÔÃâÒßȱÏݲ¡,primary immunodeficiencyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼±ÐÔÌØ·¢ÐÔѪС°å¼õÉÙÐÔ×Ïñ°,Acute idiopathic thrombocytopenic purpuraÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂÖ×´²¡¶¾¸¹Ðº,Rotavirus diarrheaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éç»á¾­¼Ãѧ,Social economicsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌØ·¢ÐԷκ¬ÌúѪ»ÆËسÁ×ÅÖ¢,idiopathic pulmonary hemosiderosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼±ÐÔË®Ñù¸¹Ðº,acute watery diarrheaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒȵºËØÒÀÀµÐÍÌÇÄò²¡,Insulin dependent diabetes mellitusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÔÙ·¢ÐÔ¸¹Í´,Recurrent abdominal painÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±ûËᱶÂÈÃ×ËÉ,beclometasone dipropionateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÏÈÌìÓÞÐÍ,Down syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸¨ÖúÁÆ·¨,adjuvant therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½á³¦´«Êäʱ¼ä,colonic transit timeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉúÎï·´Ó¦µ÷½Ú¼Á,Biological response modifierÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éö²¡Àí,Renal pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÍâÖܾ²ÂöѪ,peripheral venous bloodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³¦Ñª¹Ü»îÐÔ¶àëÄ,vasoactive intestinal peptideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´­Ï¢ÐÔ¼²²¡,Asthmatic diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ó¦Á¦Öµ,stress valueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌåÍâ×é×°,Assembly in vitroÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÔöʳÓûËØA,Orexin AÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ѫºìµ°°×(Hb),hemoglobin (Hb)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²Ð²î·ÖÎö,residual analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ʵÑéÊÒÆÀ¹À,laboratory evaluationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °±»ùËá×¢ÉäÒº,amino acid injectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÅçÉäÎí»¯,spray atomizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈËÀàðåÕ¶¾6ÐÍ,human herpesvirus 6Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÏÈÌìÐÔ¼²²¡,Congenital diseasesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Tourette×ÛºÏÕ÷,Tourette syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Բ׶¶¯Âö¸É»ûÐÎ,Conotruncal defectsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼×»ù±û¶þËáѪ֢,methylmalonic acidemiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÎüÈëÐÔ±äÓ¦Ô­,inhalation allergenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Æ«·Î²¡¶¾,MetapneumovirusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿ÂÈøÆæB×鲡¶¾,coxsackie B virusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ΢ÉúÎïÃô¸ÐÐÔʵÑé,microbial sensitivity testsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄòËØøÊÔÑé,Urease testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹Ú×´¶¯ÂöËðÉË,coronary artery lesionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ΢С²¡¶¾B19,Parvovirus B19Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿¹À£Ññ²¡Ò©,anti-ulcer agentsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ÐȾÏà¹ØÐÔÊÉѪϸ°û×ÛºÏÕ÷,infection-associated hemophagocytic syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Pierre Robin×ÛºÏÕ÷,Pierre Robin syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ºôÎüµÀÖØËÜ,Airway remodelingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÓÕµ¼ÌµÒº,Induced sputumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ¨ÑÎÊä³ö±Ã,Bile salt export pumpÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °«Ð¡¶ùͯ,microsomia childrenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¦Á-ϸÐÁÄÔ×¢ÉäÒº,¦Á-asarone injectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« McCune-Albright×ÛºÏÕ÷,McCune-Albright syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×óÐÄ·¿Ôö´ó,Left atrial enlargementÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« TBX5»ùÒò,TBX5 geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿Ú·þ¿¹ÉúËØ,oral antibioticsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ëľý×ӺϼÁ,Sijunzi MixtureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« GÐÍ,G typeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸´ÔÓ»ûÐÎ,Complex abnormalityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑÎËáÈáºìùËØ,daunorubicin hydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈËÀà¶ËÁ£Ã¸´ß»¯Ñǵ¥Î»,Human telomerase reverse transcriptaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °×ÈýÏ©E4,leukotriene E4Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« º£°²ÏØ,Haian CountyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÖØ×é¸ÉÈÅËØ,Recombinant interferonÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ҽѧͼÏñ¿ÉÊÓ»¯,medical image visualizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²»Í¬ÖÎÁÆ·½·¨,Different treatment methodsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °¢ÌÇÏÙÜÕ,vidarabineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌúÔªËØ,ironÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µÍÈéÌÇÄÌ·Û,low lactose milk powderÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌÇÔ­Á×Ëữø,glycogen phosphorylaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
 ÉÏÒ»Ò³ 7 8 9 10 11 12 13 14 ÉÏÒ»Ò³